# Bioavailability Study of BIA 5-453

> **NCT03090568** · PHASE1 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 12 (actual)

## Conditions studied

- Hypertension
- Congestive Heart Failure

## Interventions

- **DRUG:** BIA 5-453

## Key facts

- **NCT ID:** NCT03090568
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-15
- **Primary completion:** 2008-08-14
- **Final completion:** 2008-08-14
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03090568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03090568, "Bioavailability Study of BIA 5-453". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03090568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*